跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 75 条关于
“BAT1806/BIIB800”
全部
75
临床试验
58
药物
7
机构
0
资讯
10
2年前
TOFIDENCE Biosimilar Shows Sustained Efficacy and Safety in Rheumatoid Arthritis
去年
FDA Accepts Biosimilar Application for BAT2506, Proposed Golimumab Alternative
去年
Bio-Thera Solutions Initiates Phase 3 Trial for BAT8006 ADC in Platinum-Resistant Ovarian Cancer
3年前
First RoActemra Biosimilar Tyenne Receives EU Approval, Marking Milestone for Fresenius Kabi
去年
Bio-Thera Solutions Receives Positive CHMP Opinion for Ustekinumab Biosimilar USYMRO
去年
Biogen's BIIB080 Receives FDA Fast Track Designation for Alzheimer's Disease Treatment
去年
EMA Accepts Bio-Thera's Marketing Application for BAT2506, First Chinese-Developed Golimumab Biosimilar
6个月前
Bio-Thera Solutions Expands Partnership with Intas for Golimumab Biosimilar BAT2506 in India
2年前
Bio-Thera Solutions' Ustekinumab Biosimilar BAT2206 Gains Regulatory Acceptance in US and EU
2年前
Bio-Thera's BAT8006 Shows Promising 37% Response Rate in Platinum-Resistant Ovarian Cancer Phase I Trial